Bausch Health Companies Inc. (NYSE:BHC – Get Free Report) was the target of unusually large options trading activity on Monday. Investors bought 5,611 put options on the stock. This represents an increase of approximately 50% compared to the typical daily volume of 3,735 put options.
Bausch Health Companies Stock Up 10.8 %
NYSE:BHC opened at $7.00 on Tuesday. The stock has a market cap of $2.53 billion, a PE ratio of -5.65 and a beta of 0.75. Bausch Health Companies has a fifty-two week low of $3.96 and a fifty-two week high of $11.46. The firm’s fifty day simple moving average is $6.24 and its 200-day simple moving average is $7.38.
Bausch Health Companies (NYSE:BHC – Get Free Report) last issued its quarterly earnings data on Thursday, August 1st. The company reported $0.98 EPS for the quarter, beating analysts’ consensus estimates of $0.89 by $0.09. Bausch Health Companies had a negative net margin of 5.12% and a negative return on equity of 742.06%. The firm had revenue of $2.40 billion for the quarter, compared to analysts’ expectations of $2.33 billion. During the same period in the prior year, the company earned $0.81 EPS. Equities analysts anticipate that Bausch Health Companies will post 3.61 earnings per share for the current year.
Wall Street Analyst Weigh In
Check Out Our Latest Report on BHC
Insiders Place Their Bets
In other Bausch Health Companies news, EVP Seana Carson sold 13,370 shares of the business’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $6.21, for a total value of $83,027.70. Following the sale, the executive vice president now owns 435,198 shares in the company, valued at approximately $2,702,579.58. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 8.12% of the company’s stock.
Institutional Inflows and Outflows
Several hedge funds have recently bought and sold shares of BHC. Clearline Capital LP acquired a new stake in shares of Bausch Health Companies during the second quarter worth approximately $6,881,000. Mackenzie Financial Corp raised its stake in shares of Bausch Health Companies by 111.0% during the second quarter. Mackenzie Financial Corp now owns 2,381,888 shares of the company’s stock valued at $16,612,000 after purchasing an additional 1,252,834 shares in the last quarter. The Manufacturers Life Insurance Company raised its position in Bausch Health Companies by 2.0% in the second quarter. The Manufacturers Life Insurance Company now owns 246,808 shares of the company’s stock worth $1,719,000 after acquiring an additional 4,944 shares in the last quarter. Maverick Capital Ltd. bought a new stake in Bausch Health Companies in the second quarter worth about $1,606,000. Finally, MQS Management LLC bought a new stake in Bausch Health Companies in the second quarter worth about $71,000. Hedge funds and other institutional investors own 78.65% of the company’s stock.
About Bausch Health Companies
Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.
Featured Articles
- Five stocks we like better than Bausch Health Companies
- What Are Trending Stocks? Trending Stocks Explained
- Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible
- Stock Analyst Ratings and Canadian Analyst Ratings
- Roblox’s Growth Beyond Kids: Stock Set for Major Moves
- Market Cap Calculator: How to Calculate Market Cap
- 5 Oversold Stocks to Buy Right Now
Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with MarketBeat.com's FREE daily email newsletter.